Approach to the prevention of atypical hemolytic uremic syndrome recurrence using eculizumab in a pregnant kidney transplant recipient with complement factor H gene mutation: a case report and literature review.
使用 eculizumab 預防帶有補體因子 H 基因突變的孕期腎臟移植受者非典型溶血性尿毒症症候群復發之處置:病例報告與文獻回顧
J Nephrol 2025-07-11
Trends in Outcomes Among Patient Initiating Peritoneal Dialysis in the United States, 2009-2018.
2009至2018年間美國新開始腹膜透析患者的治療結果趨勢
Am J Kidney Dis 2025-07-11
Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression.
Phosphoenolpyruvate carboxykinase 1 介導的 cataplerosis 維持粒線體健康並避免腎臟疾病惡化所必需
Kidney Int 2025-07-11
Iohexol clearance, but not estimated GFR, reveals a steeper GFR decline in patients with prediabetes.
Iohexol 清除率(Iohexol clearance),而非估算腎絲球過濾率(estimated GFR),可揭示有糖尿病前期患者較陡峭的腎絲球過濾率下降。
Kidney Int 2025-07-11
Thresholds of Kidney Function Decline and Congestion Status and Their Relation with Outcomes Among Discharged Heart Failure Patients.
腎功能下降與鬱血狀態的臨界值及其與出院心臟衰竭患者預後的關聯
Clin J Am Soc Nephrol 2025-07-11
Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.
IgA腎病患者個人化風險預測模型的開發與驗證:全國多中心隊列研究
J Nephrol 2025-07-11
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR.
Asymmetric dimethylarginine 與 citrulline 為心血管疾病的風險因子,且其影響獨立於估算與實測 GFR。
Clin Kidney J 2025-07-11